UK Markets closed

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,795.00-19.00 (-0.22%)
At close: 4:35PM BST
Full screen
Previous close8,814.00
Bid8,779.00 x 0
Ask8,780.00 x 0
Day's range8,750.00 - 8,848.00
52-week range6,499.80 - 9,081.00
Avg. volume3,318,154
Market cap115.458B
Beta (5Y monthly)0.19
PE ratio (TTM)40.47
Earnings dateN/A
Forward dividend & yield2.02 (2.37%)
Ex-dividend date12 Aug 2021
1y target estN/A
  • Motley Fool

    Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?

    In this Motley Fool Live video recorded on Oct. 6, Motley Fool contributors Keith Speights and Brian Orelli discuss how big the market opportunity might be for AstraZeneca's COVID-19 therapy. Keith Speights: On Tuesday, AstraZeneca filed for Emergency Use Authorization for its COVID-19 antibody therapy.

  • Yahoo Finance Video

    NIH Director on FDA ‘being careful’ in clearing Moderna vaccine for kids 12-17

    Dr. Francis Collins, Outgoing NIH Director, joins Yahoo Finance’s Anjalee Khemlani to discuss Covid-19 vaccine production, drug development research, and misinformation surrounding Covid-19 vaccines.

  • Motley Fool

    The Smartest Stocks to Buy With $200 Right Now

    Brokerages' race to the bottom in trading fees has been a breakthrough in helping to make investing less cumbersome to newcomers. While high commissions used to be a costly obstacle for new investors and discouraged some from investing altogether, that's now less of an issue. In fact, a recent study by discount broker Charles Schwab found that 15% of current U.S. investors bought their first shares just last year.